{
    "clinical_study": {
        "@rank": "89013", 
        "acronym": "HIV/TB", 
        "arm_group": {
            "arm_group_label": "one arm", 
            "arm_group_type": "Other", 
            "description": "All patients with response to positive purified protein derivative (PPD) test are treated"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine of once identified to the subjects infected with\n      human immunodeficiency virus (positive VIH), to diagnose latent Tuberculosis, and to treat\n      her with isoniazid for six months, measuring the production of Interferon range pre and\n      posttreatment, to evaluate this way the result of the treatment on the immune response"
        }, 
        "brief_title": "Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Human Immunodeficiency Virus (HIV)", 
            "Tuberculosis (TB)", 
            "Latent Tuberculosis Infection (LTI)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Immunologic Deficiency Syndromes", 
                "Tuberculosis", 
                "Latent Tuberculosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "A descriptive analysis of the data will be made. Means and standard deviations for\n      continuous data frequencies for categorical data will be performed. Wilcoxon test\n      Mann-Whitney U test Chi square will be used for frequency analysis of responders Data\n      Analysis and Statistical Software(STATA)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Accept to participate.  Informed consent.\n\n          -  Human Immunodeficiency Virus positive test, documented by Western Blot\n\n          -  Have not received treatment for latent tuberculosis\n\n          -  Have not been diagnosed pulmonary tuberculosis (Tbp)\n\n          -  Normal two chest X-rays, Postern-anterior and left lateral.\n\n        Exclusion Criteria:\n\n          -  Active tuberculosis\n\n          -  Previous diagnosis of tuberculosis\n\n          -  Antecedent of treatment  for active o latent tuberculosis\n\n          -  Contact  with  TB patient harboring Multidrug resistance  or isoniazid resistant\n             isolates of Mycobacterium tuberculosis.\n\n          -  Abnormal liver enzyme levels\n\n          -  Hemoglobin below 8 gr/dl\n\n          -  Allergy or intolerance  to isoniazid\n\n          -  Peripheral neuropathy\n\n          -  Ingestion of drugs interacting with isoniazid"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875952", 
            "org_study_id": "Informed Consent:552 / 306", 
            "secondary_id": "000000000014520"
        }, 
        "intervention": {
            "arm_group_label": "one arm", 
            "description": "Isoniazid, 10 mg/Kg/day, no more than 300 mg/day, for six months", 
            "intervention_name": "Isoniazid", 
            "intervention_type": "Drug", 
            "other_name": "Isoniazid"
        }, 
        "intervention_browse": {
            "mesh_term": "Isoniazid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Latent tuberculosis infection", 
            "Human immunodeficiency virus (HIV)", 
            "Treatment", 
            "Isoniazid"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mexico", 
                        "country": "Mexico", 
                        "state": "Cuernavaca Morelos", 
                        "zip": "62100"
                    }, 
                    "name": "Instituto Nacional de Salud Publica"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "state": "D.F", 
                        "zip": "06140"
                    }, 
                    "name": "Cl\u00ednica Especializada CONDESA"
                }
            }
        ], 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "1", 
        "official_title": "Integral Research of the Managing and Treatment of the Infection With Human Immunodeficiency (VIH) /Human Immunodeficiency Syndrome(SIDA) Co-infection With Latent Tuberculosis Infection. A Multidisciplinary and Interinstitucional Approach", 
        "overall_official": [
            {
                "affiliation": "Instituto Nacional de Ciencias Medicas y Nitrici\u00f3n Salvador Zubiran (INCMNSZ)", 
                "last_name": "Jos\u00e9 Sifuentes, Doctor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Instituto Nacional de Ciencias Medicas y Nutrici\u00f3n  (INCMNSZ)", 
                "last_name": "Alfredo Ponce-de-Le\u00f3n, Doctor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Instituto Nacional de Salud Publica (INSP)", 
                "last_name": "Maria de Lourdes Garc\u00eda-Garc\u00eda, Post doctor", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Laboratorios Nacionales de Biol\u00f3gicos y Reactrivos (BIRMEX)", 
                "last_name": "Jose Luis Valdespino-G\u00f3mez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Institute of Respiratory Diseases (INER)", 
                "last_name": "Martha Torres Rojas, Post Doctor", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Mexico: National Institute of Public Health, Health Secretariat", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Production of interferon gamma, in response to treatment of latent infection", 
            "safety_issue": "Yes", 
            "time_frame": "Before and after treatment intake"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875952"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Instituto Nacional de Salud Publica, Mexico", 
            "investigator_full_name": "Ma. de Lourdes Garcia Garcia", 
            "investigator_title": "Director of the Center of Research in Infectious Diseases", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Instituto Nacional de Salud Publica, Mexico", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Instituto Nacional de Enfermedades Respiratorias", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Instituto Nacional de Salud Publica, Mexico", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}